Zisson Alex

CIK 00015120584 companiesMINNEAPOLIS, MN

SEC Profile

Transactions

Companies

Filings

CIK

0001512058

Recent Transactions

50 trades

Award
Clarus Therapeutics Holdings, Inc.
Common Stock
2021-09-09+490,531→ 490,531 total
Award
Clarus Therapeutics Holdings, Inc.
Common Stock
2021-09-09+2,731,094→ 3,221,625 total
Award
Clarus Therapeutics Holdings, Inc.
Common Stock
2021-09-09+2,470,756→ 5,692,381 total
Disposition from Tender
Auspex Pharmaceuticals, Inc.
Common Stock
2015-05-05−4,835,731→ 0 total
Sale
Auspex Pharmaceuticals, Inc.
Common Stock
2015-01-28$53.11/sh−730,000→ 4,835,731 total
Exercise/Conversion
Auspex Pharmaceuticals, Inc.
Common Stock Warrant
2015-01-08−169,630→ 0 total
Exercise/Conversion
Auspex Pharmaceuticals, Inc.
Common Stock
2015-01-08$3.88/sh+319,135→ 5,589,739 total
Exercise/Conversion
Auspex Pharmaceuticals, Inc.
Common Stock Warrant
2015-01-08−59,277→ 0 total
Exercise/Conversion
Auspex Pharmaceuticals, Inc.
Common Stock Warrant
2015-01-08−90,228→ 0 total
Disposition to Issuer
Auspex Pharmaceuticals, Inc.
Common Stock
2015-01-08$51.57/sh−24,008→ 5,565,731 total
Disposition to Issuer
Auspex Pharmaceuticals, Inc.
Common Stock
2014-10-09$23.89/sh−9,771→ 5,270,604 total
Exercise/Conversion
Auspex Pharmaceuticals, Inc.
Common Stock
2014-10-09$3.88/sh+60,151→ 5,280,375 total
Exercise/Conversion
Auspex Pharmaceuticals, Inc.
Common Stock Warrent
2014-10-09−60,151→ 0 total
Exercise/Conversion
Auspex Pharmaceuticals, Inc.
Common Stock
2014-05-14$3.88/sh+65,839→ 5,232,624 total
Disposition to Issuer
Auspex Pharmaceuticals, Inc.
Common Stock
2014-05-14$20.60/sh−12,400→ 5,220,224 total
Exercise/Conversion
Auspex Pharmaceuticals, Inc.
Common Stock Warrants
2014-05-14−65,839→ 0 total
Sale
Auspex Pharmaceuticals, Inc.
Common Stock
2014-05-14$20.60/sh−12,400→ 5,220,224 total
Exercise of In-Money
Auspex Pharmaceuticals, Inc.
Common Stock
2014-05-14$3.88/sh+65,839→ 5,232,624 total
Exercise of In-Money
Auspex Pharmaceuticals, Inc.
Common Stock Warrants
2014-05-14−65,839→ 0 total
Conversion
Auspex Pharmaceuticals, Inc.
Series B Convertible Preferred Stock
2014-02-10−2,289,771→ 0 total
Purchase
Auspex Pharmaceuticals, Inc.
Common Stock
2014-02-10$12.00/sh+83,334→ 5,166,785 total
Conversion
Auspex Pharmaceuticals, Inc.
Series C Convertible Preferred Stock
2014-02-10−7,552,207→ 0 total
Conversion
Auspex Pharmaceuticals, Inc.
Common Stock
2014-02-10+5,083,451→ 5,083,451 total
Conversion
Auspex Pharmaceuticals, Inc.
Series D Convertible Preferred Stock
2014-02-10−11,915,254→ 0 total
Conversion
Auspex Pharmaceuticals, Inc.
Series E Convertible Preferred Stock
2014-02-10−1,118,298→ 0 total
Conversion
Auspex Pharmaceuticals, Inc.
Preferred Stock Warrant
2014-02-10−296,281→ 0 total
Conversion
Auspex Pharmaceuticals, Inc.
Common Stock Warrant
2014-02-10+65,839→ 65,839 total
Conversion
Auspex Pharmaceuticals, Inc.
Preferred Stock Warrant
2014-02-10−270,687→ 0 total
Conversion
Auspex Pharmaceuticals, Inc.
Common Stock Warrant
2014-02-10+60,151→ 60,151 total
Conversion
Auspex Pharmaceuticals, Inc.
Preferred Stock Warrant
2014-02-10−266,750→ 0 total
Conversion
Auspex Pharmaceuticals, Inc.
Common Stock Warrant
2014-02-10+59,277→ 59,277 total
Conversion
Auspex Pharmaceuticals, Inc.
Preferred Stock Warrant
2014-02-10−763,340→ 0 total
Conversion
Auspex Pharmaceuticals, Inc.
Common Stock Warrant
2014-02-10+169,630→ 169,630 total
Conversion
Auspex Pharmaceuticals, Inc.
Preferred Stock Warrant
2014-02-10−406,032→ 0 total
Conversion
Auspex Pharmaceuticals, Inc.
Common Stock Warrant
2014-02-10+90,228→ 90,228 total
Other
Ocera Therapeutics, Inc.
Common Stock, par value $0.00001 per share
2013-07-15$6.00/sh+2,500,002→ 2,500,002 total
Other
Ocera Therapeutics, Inc.
Common Stock, par value $0.00001 per share
2013-07-15$6.00/sh+762,892→ 762,892 total
Other
Ocera Therapeutics, Inc.
Common Stock, par value $0.00001 per share
2013-07-15$6.00/sh+1,675,677→ 1,675,677 total
Award
Celator Pharmaceuticals Inc
Stock Option (right to buy)
2013-06-03+28,000→ 28,000 total
Award
Ocera Therapeutics, Inc.
Warrants
2012-10-01$44.23/sh+161,855→ 161,855 total
Award
Ocera Therapeutics, Inc.
Stock Option (Right to Buy)
2012-08-07+31,835→ 31,835 total
Award
Ocera Therapeutics, Inc.
Stock Option (Right to Buy)
2012-08-07+31,835→ 31,835 total
Award
Ocera Therapeutics, Inc.
Stock Option (Right to Buy)
2012-08-07+31,835→ 31,835 total
Award
Ocera Therapeutics, Inc.
Warrants
2012-03-30$44.23/sh+161,855→ 161,855 total
Award
Ocera Therapeutics, Inc.
Stock Option (Right to Buy)
2011-04-19+25,000→ 25,000 total
Award
Ocera Therapeutics, Inc.
Stock Option (right to buy)
2011-04-19+25,000→ 25,000 total
Award
Ocera Therapeutics, Inc.
Stock Option (Right to Buy)
2011-04-19+25,000→ 25,000 total
Conversion
Ocera Therapeutics, Inc.
Series A Convertible Preferred Stock
2011-04-06−55,946→ 0 total
Purchase
Ocera Therapeutics, Inc.
Common Stock
2011-04-06$4.00/sh+794,966→ 2,984,752 total
Conversion
Ocera Therapeutics, Inc.
Series A Convertible Preferred Stock
2011-04-06−14,725,374→ 0 total

Companies

Recent Filings

Address

C/O THOMAS, MCNERNEY & PARTNERS 60 SOUTH SIXTH STREET, SUITE 3620

MINNEAPOLIS, MN, 55402

View on SEC.gov